Scroll to top

The Northeast Node of the National Drug Abuse Treatment Clinical Trials Network receives NIDA funding to study a pharmacist-integrated model of medication treatment for opioid use disorder

While studies have engaged pharmacists in dispensing medications in opioid use disorder (MOUD) treatment, few studies have evaluated collaborative care models in which pharmacists are an active, integral part of a primary care team offering opioid use disorder (OUD) care.  The project, Pharmacist-Integrated Model of Medication Treatment for Opioid Use Disorder aims to evaluate the feasibility and acceptability of implementing a pharmacist-integrated model of MOUD treatment into the clinical workflow and to examine the impact of this model on the clinical sites’ capacity for MOUD care and on patient engagement in OUD care.